Kintara Therapeutics Inc.
13F holders, Q1 2024 (March 31)13holders
$0.10avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Kintara Therapeutics Inc. in their 13F filings. The largest holders were UBS Group AG ($14K), Susquehanna International Group, LLP ($10K) and HRT Financial LP ($8K).
- Company
- Kintara Therapeutics Inc.
- CUSIP
- 49720K200
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $41K |
| Exits | 2 | $3K |
Ownership 13 holders
| UBS Group AG | 0.00% | New | 138,632 | $14K |
| Susquehanna International Group, LLP | 0.00% | New | 100,788 | $10K |
| HRT Financial LP | 0.00% | New | 81,604 | $8K |
| Jane Street Group, LLC | 0.00% | New | 69,361 | $7K |
| Geode Capital Management, LLC | 0.00% | No change | 43,163 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +277.1% | 18,310 | $2K |
| Vanguard Group Inc. | 0.00% | No change | 12,455 | $1K |
| Nantahala Capital Management, LLC | 0.00% | Reduce -42.0% | 12,763 | $1K |
| State Street Corp. | 0.00% | No change | 10,721 | $1K |
| Qube Research & Technologies Ltd | 0.00% | New | 6,600 | $686 |
| Osaic Holdings, Inc. | 0.00% | No change | 949 | $94 |
| Wells Fargo & Company | 0.00% | Add +100.0% | 26 | $3 |
| Acadian Asset Management LLC | 0.00% | Reduce -99.7% | 350 | $0 |
"% of holder's portfolio" is KINTARA THERAPEUTICS INC's weight in each manager's 13F, not the share of Kintara Therapeutics Inc. the manager owns.